Magnetic Resonance Imaging in Parkinsonism
- 1 May 1992
- journal article
- review article
- Published by Elsevier in Neurologic Clinics
- Vol. 10 (2) , 405-420
- https://doi.org/10.1016/s0733-8619(18)30218-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine NeuronsJournal of Neurochemistry, 1991
- BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigraNature, 1991
- Non‐invasive quantitation of liver iron‐overload by magnetic resonance imagingBritish Journal of Haematology, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Receptor‐mediated transcytosis of transferrin across the blood‐brain barrierJournal of Neuroscience Research, 1987
- Magnetic resonance imaging of the midbrain in Parkinson's diseaseAnnals of Neurology, 1986
- Magnetic-Susceptibility Measurement of Human Iron StoresNew England Journal of Medicine, 1982
- The effects of iron deficiency on brain biogenic monoamine biochemistry and function in ratsNeuropharmacology, 1980